Published in J Neurol Sci on February 23, 2016
Isolated transient myoclonus in the elderly: an under-recognized condition? Clin Neurol Neurosurg (2013) 2.04
Necklace cytoplasmic bodies in hereditary myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry (2014) 1.39
First adult case of Helicobacter cinaedi meningitis. J Neurol Sci (2013) 0.91
Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes. Muscle Nerve (2015) 0.89
Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2014) 0.87
Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol (2015) 0.87
Guillain-Barré syndrome in Asia. J Neurol Neurosurg Psychiatry (2013) 0.84
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria. Mult Scler (2015) 0.83
Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging (2015) 0.82
Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open (2015) 0.82
Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI. J Neurol Sci (2015) 0.81
Steroid-Responsive Epilepsia Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy? Case Rep Neurol (2014) 0.79
Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry (2014) 0.79
Serum high mobility group box 1 is upregulated in myasthenia gravis. J Neurol Neurosurg Psychiatry (2014) 0.78
Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry (2015) 0.78
Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study. J Neurol Sci (2015) 0.78
Incidental diagnosis of an asymptomatic adult-onset Alexander disease by brain magnetic resonance imaging for preoperative evaluation. J Neurol Sci (2015) 0.77
Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes. PLoS One (2014) 0.77
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption. Mult Scler (2016) 0.76
Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol (2016) 0.76
Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry (2016) 0.76
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis? J Neurol Neurosurg Psychiatry (2014) 0.75
Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2015) 0.75
Corticosteroid-responsive leptomeningitis with IgG4-positive plasma-cell infiltration. J Neurol Sci (2015) 0.75
Reply to letter to the Editor: isolated transient myoclonus in the elderly. Clin Neurol Neurosurg (2014) 0.75
Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease. PLoS One (2015) 0.75
A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells. Neurotherapeutics (2016) 0.75
Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies. J Neurol Neurosurg Psychiatry (2015) 0.75
Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.75
[Neurophysiologic assessment of disorders affecting the neuromuscular junction]. Brain Nerve (2011) 0.75
Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies. J Neurol Neurosurg Psychiatry (2017) 0.75
A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain. Clin Neurol Neurosurg (2013) 0.75
Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation. J Neurol Sci (2017) 0.75
Timing is crucial for electrodiagnosis of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2014) 0.75
Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies. Neuromuscul Disord (2016) 0.75
Peripheral-type facial palsy as an initial symptom of lateral medullary infarction. Acta Neurol Belg (2022) 0.75
Flecainide ameliorates arrhythmogenicity through NCX flux in Andersen-Tawil syndrome-iPS cell-derived cardiomyocytes. Biochem Biophys Rep (2017) 0.75
Benign neuromyelitis optica is rare in Japanese patients. Mult Scler (2014) 0.75
Brain gray matter structural network in myotonic dystrophy type 1. PLoS One (2017) 0.75
Vogt-Koyanagi-Harada disease with meningitis-retention syndrome and increased CSF adenosine deaminase levels. Clin Neurol Neurosurg (2014) 0.75
Muscle haematoma due to antithrombotic treatment for ischaemic stroke. J Clin Neurosci (2015) 0.75
Hydrocephalus due to marked enlargement of spinal roots in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol (2020) 0.75
Recurrent, alternating orbital inflammation. J Neurol Sci (2015) 0.75
Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PLoS One (2017) 0.75
Pneumocephalus associated with Pott's puffy tumor. J Neurol Sci (2016) 0.75
The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement. J Neuroimmunol (2019) 0.75
Acute hemicerebellitis in a young adult: a case report and literature review. J Neurol Sci (2014) 0.75
Transient global amnesia with a hippocampal lesion followed by transient epileptic amnesia. Seizure (2015) 0.75
Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry (2017) 0.75
Chronic inflammatory demyelinating polyneuropathy with membranous nephropathy. J Peripher Nerv Syst (2015) 0.75
Reply. Muscle Nerve (2016) 0.75
Rapidly progressive Aspergillus meningitis successfully treated with voriconazole and corticosteroids. Neurol Sci (2017) 0.75
Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy. J Neuroimmunol (2022) 0.75
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. J Neuroimmunol (2015) 0.75
Pain-related evoked potentials after intraepidermal electrical stimulation to Aδ and C fibers in patients with neuropathic pain. Neurosci Res (2017) 0.75
Paraparetic Guillain-Barré syndrome: Nondemyelinating reversible conduction failure restricted to the lower limbs. Muscle Nerve (2016) 0.75
Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity. J Neuroimmunol (2017) 0.75
Clinical and magnetic resonance imaging features of elderly onset dentatorubral-pallidoluysian atrophy. J Neurol (2017) 0.75
Headache attributed to aeroplane travel and reversible cerebral vasoconstriction syndrome. Cephalalgia (2016) 0.75
Cryptococcosis mimicking lung cancer with brain metastasis. Clin Neurol Neurosurg (2015) 0.75
A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J Neurol Neurosurg Psychiatry (2016) 0.75
Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis. J Neurol Sci (2015) 0.75
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry (2017) 0.75